1. Chen J., Zhang D., Yan W., Yang D., Shen B. Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era. BioMed Res. Int. 2013;2013:901578. doi: 10.1155/2013/901578. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 2. Hjelmborg J.B., Scheike T., Holst K., Skytthe A., Penney K.L., Graff R.E., Pukkala E., Christensen K., Adami H.-O., Holm N.V., et al. The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol. Biomark. Prev. 2014;23:2303–2310. doi: 10.1158/1055-9965.EPI-13-0568. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 3. Termini D., Hartogh D.J.D., Jaglanian A., Tsiani E. Curcumin against Prostate Cancer: Current Evidence. Biomolecules. 2020;10:1536. doi: 10.3390/biom10111536. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 4. Wen S., Chang H.-C., Tian J., Shang Z., Niu Y., Chang C. Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer. Am. J. Pathol. 2015;185:293–301. doi: 10.1016/j.ajpath.2014.10.012. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 5. Cittadini A., Isidori A.M., Salzano A. Testosterone therapy and cardiovascular diseases. Cardiovasc.